ClinicalTrials.gov
public full text
Public Domain
Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome
To demonstrate the superiority of IMP (1% OPA-15406 ointment or vehicle) to the vehicle when administered twice daily for 4 weeks using success rate in Investigator's Global Assessment (IGA) at Week 4 as the primary endpoint in adult patients with AD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis#1137892
- A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis#828069
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis#912874
- A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects#1058282
- Efficacy of Acupuncture in the Treatment of Moderate-to-severe Atopic Dermatitis#967293
Record · ID 968556
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive